PT
Palatin Technologies, Inc.
PTN · NASDAQ
$12.70 -1.01% (-$0.13)
1M +72.55%
Market Cap $22.6M
P/E Ratio -
Div. Yield -
ROE 141.41%
Bulios Fair Price
$11.68
8.0% downside
Current Price
$12.7
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PTN is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
84 /100
Cheap P/B 2.13x
P/S 1.75x
P/FFO N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 48.50%
Op. margin 50.60%
FCF margin 116.29%
Quality
12 /100
Poor ROE 141.41%
ROA 47.25%
Asset turnover 0.97x
Debt
69 /100
Low Current ratio 5.04x
Int. coverage -860.47x
Debt/Equity 0.03x
Stability
13 /100
Unstable Rev. volatility 170.52%
EPS volatility 875.84%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PTN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Carl Spana
Employees
29
Headquarters
Monmouth Junction
Upcoming events
16 NOV
Earnings
Upcoming earnings report